The Global Immuno-Oncology Assays Market is estimated to be valued at US$ 5249.47 Mn in 2024 and is expected to exhibit a CAGR of 4.3% over the forecast period from 2024 to 2030.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |